Chapter 52: Drugs Affecting the Urinary Tract & Bladder

Treatment for UTIs involves urinary tract antiinfectives, which include specific antibiotics like fosfomycin (often prescribed as a single dose for uncomplicated UTIs) and trimethoprim, effective against Gram-negative bacteria, and agents such as methenamine and methylene blue, which function by the process of acidification, making the urine environment inhospitable for bacterial survival. Crucial nursing considerations for antiinfectives involve promoting patient hygiene, avoiding substances that cause alkaline ash (like citrus juices), and encouraging abundant fluid intake to flush the bladder. To address painful muscle contractions stemming from irritation or neurogenic bladder, urinary tract antispasmodics are employed, primarily composed of anticholinergic drugs like oxybutynin and tolterodine, which block parasympathetic activity to induce relaxation of the detrusor muscle, reducing symptoms such as frequency, urgency, and nocturia. A contrasting agent, mirabegron, is a beta-agonist that achieves detrusor muscle relaxation via sympathetic stimulation. For symptomatic relief of urinary tract irritation related to infection or trauma, the topical analgesic phenazopyridine is administered, relieving burning and pain, but patients must be cautioned that this dye will cause a reddish-orange discoloration of the urine and may stain contact lenses or fabrics. Interstitial cystitis, characterized by chronic bladder inflammation, is treated using the bladder protectant pentosan polysulfate sodium, a heparin-like substance that adheres to the bladder mucosal wall, acting as a buffer against irritating solutes. Due to its anticoagulant and fibrinolytic effects, pentosan carries a significant risk of bleeding and is contraindicated in patients with conditions involving increased bleeding risk. Finally, the enlargement of the prostate gland known as BPH is managed using two primary drug classes: alpha-adrenergic blockers such as doxazosin and tamsulosin, which relax muscles in the urinary tract to ease urine flow, and testosterone production blockers like finasteride and dutasteride. The latter inhibit the conversion of testosterone to dihydrotestosterone (DHT), gradually shrinking the prostate gland, but pose serious risks to a developing fetus and require women of childbearing age to avoid handling the tablets. Comprehensive nursing care across all categories includes careful monitoring of renal and hepatic function, assessing for potential adverse effects (like hypotension with alpha-blockers or sexual dysfunction with androgen blockers), and ensuring patients comply with long-term therapy and lifestyle modifications.